We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 206 results
  1. A new integrative analysis of histopathology and single cell RNA-seq reveals the CCL5 mediated T and NK cell interaction with vascular cells in idiopathic pulmonary arterial hypertension

    Background

    Inflammation and dysregulated immunity play vital roles in idiopathic pulmonary arterial hypertension (IPAH), while the mechanisms that...

    **ncheng Li, Shuangshuang Ma, ... Zhenguo Zhai in Journal of Translational Medicine
    Article Open access 26 May 2024
  2. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

    Background

    Pulmonary arterial hypertension (PAH) is a lethal vasculopathy characterized by pathogenic remodeling of pulmonary arterioles leading to...

    Na Zhu, Emilia M. Swietlik, ... Wendy K. Chung in Genome Medicine
    Article Open access 10 May 2021
  3. Pulmonary Hypertension

    The progressive and devastating disorder of pulmonary hypertension is associated with vascular remodelling and vascular rarefaction. This escalates...
    Sudipto Saha, Sreyashi Majumdar, Parthasarathi Bhattacharyya in Pulmonomics: Omics Approaches for Understanding Pulmonary Diseases
    Chapter 2023
  4. Protein O-GlcNAcylation in cardiovascular diseases

    O -GlcNAcylation is a post-translational modification of protein in response to genetic variations or environmental factors, which is controlled by...

    Hui-fang Wang, Yi-xuan Wang, ... Zhi-cheng **g in Acta Pharmacologica Sinica
    Article 11 July 2022
  5. Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension

    Background

    Group 1 pulmonary arterial hypertension (PAH) is a rare disease with high mortality despite recent therapeutic advances. Pathogenic...

    Na Zhu, Michael W. Pauciulo, ... William C. Nichols in Genome Medicine
    Article Open access 14 November 2019
  6. Recent advances in endothelial colony-forming cells: from the transcriptomic perspective

    Endothelial colony-forming cells (ECFCs) are progenitors of endothelial cells with significant proliferative and angiogenic ability. ECFCs are a...

    Yaqiong Liu, Caomhán J. Lyons, ... Timothy O’Brien in Journal of Translational Medicine
    Article Open access 26 March 2024
  7. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

    Pulmonary arterial hypertension (PAH) is a multifactorial disease associated with the remodeling of pulmonary blood vessels. If left unaddressed, PAH...

    Jaydev Dave, Vineeta Jagana, ... Malik Bisserier in Journal of Translational Medicine
    Article Open access 17 July 2023
  8. Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-β signalling

    Pulmonary arterial hypertension (PAH) is a devastating disease, characterized by obstructive pulmonary vascular remodelling ultimately leading to...

    Kondababu Kurakula, Quint A. J. Hagdorn, ... Rolf M. F. Berger in Angiogenesis
    Article Open access 11 August 2021
  9. Nets, pulmonary arterial hypertension, and thrombo-inflammation

    Abstract

    Pulmonary arterial hypertension (PAH) is a progressive and fatal vascular disease in which high blood pressure in the pulmonary artery and...

    Luís Pedro Baptista de Barros Ribeiro Dourado, Mário Santos, Daniel Moreira-Gonçalves in Journal of Molecular Medicine
    Article 20 April 2022
  10. Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension

    According to the World Symposium Pulmonary Hypertension (WSPH) classification, pulmonary hypertension (PH) is classified into five categories based...
    Shuxin Liang, Ankit A. Desai, ... Haiyang Tang in Lung Inflammation in Health and Disease, Volume I
    Chapter 2021
  11. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases

    Cardiovascular disease (CVD) is the leading cause of disease-related death worldwide and a significant obstacle to improving patients’ health and...

    **ang Ao, Wei Ding, ... Ying Liu in Journal of Molecular Medicine
    Article 04 April 2023
  12. Inflammation in Pulmonary Arterial Hypertension

    Pulmonary artery hypertension (PAH) is a devastating cardiopulmonary disease characterized by vascular remodeling and obliteration of the...
    Chapter 2021
  13. Prostacyclin (PGI2) scaffolds in medicinal chemistry: current and emerging drugs

    Prostacyclin (PGI 2 ) is a natural hormone that has primarily been explored for its potent vasodilation activity and inhibition of platelet...

    Ghina’a I. Abu Deiab, Mitchell P. Croatt in Medicinal Chemistry Research
    Article 30 May 2022
  14. The role of vasculature and angiogenesis in respiratory diseases

    In European countries, nearly 10% of all hospital admissions are related to respiratory diseases, mainly chronic life-threatening diseases such as...

    Maximilian Ackermann, Christopher Werlein, ... Danny D. Jonigk in Angiogenesis
    Article Open access 05 April 2024
  15. Targeting Molecular and Cellular Mechanisms of Pulmonary Arterial Hypertension

    Pulmonary arterial hypertension (PAH) is a devastating disease of the pulmonary circulation, characterized by pulmonary vascular remodeling leading...
    Md Khadem Ali, Jay C. Horvat, Edda F. Spiekerkoetter in Targeting Cellular Signalling Pathways in Lung Diseases
    Chapter 2021
  16. Salmonella and Shigella

    Salmonellae are ubiquitous human and animal pathogens. Salmonella spp. include Gram-negative, flagellated and facultative anaerobic bacilli...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
  17. Pulmonary Arterial Hypertension

    Mario Boehm, Ralph T. Schermuly in Encyclopedia of Molecular Pharmacology
    Reference work entry 2021
  18. Pulmonary Arterial Hypertension

    Mario Boehm, Ralph T. Schermuly in Encyclopedia of Molecular Pharmacology
    Living reference work entry 2021
  19. Short reads-based characterization of pathotype diversity and drug resistance among Escherichia coli isolated from patients attending regional referral hospitals in Tanzania

    Background

    Escherichia coli is known to cause about 2 million deaths annually of which diarrhea infection is leading and typically occurs in children...

    Livin E. Kanje, Happiness Kumburu, ... Tolbert Sonda in BMC Medical Genomics
    Article Open access 26 April 2024
Did you find what you were looking for? Share feedback.